Singh D - Search Results

1

The sputum microbiome is distinct between COPD and health, independent of smoking history.

Haldar K, George L, Wang Z, Mistry V, Ramsheh MY, Free RC, John C, Reeve NF, Miller BE, Tal-Singer R, Webb AJ, Brookes AJ, Tobin MD, Singh D, Donaldson GC, Wedzicha JA, Brown JR, Barer MR, Brightling CE. Haldar K, et al. Among authors: singh d. Respir Res. 2020 Jul 14;21(1):183. doi: 10.1186/s12931-020-01448-3. Respir Res. 2020. PMID: 32664956 Free PMC article.

2

Use of different exhaled nitric oxide multiple flow rate models in COPD.

Roy K, Borrill ZL, Starkey C, Hazel AL, Morris J, Vestbo J, Singh D. Roy K, et al. Among authors: singh d. Eur Respir J. 2007 Apr;29(4):651-9. doi: 10.1183/09031936.00149706. Epub 2007 Feb 14. Eur Respir J. 2007. PMID: 17301096 Free article.

3

The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD.

Borrill ZL, Houghton CM, Tal-Singer R, Vessey SR, Faiferman I, Langley SJ, Singh D. Borrill ZL, et al. Among authors: singh d. Br J Clin Pharmacol. 2008 Feb;65(2):244-52. doi: 10.1111/j.1365-2125.2007.03013.x. Br J Clin Pharmacol. 2008. PMID: 18251761 Free PMC article. Clinical Trial.

4

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.

Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Lomas DA, et al. Thorax. 2008 Dec;63(12):1058-63. doi: 10.1136/thx.2008.102574. Epub 2008 Aug 29. Thorax. 2008. PMID: 18757456

5

Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes.

Kolsum U, Borrill Z, Roy K, Starkey C, Vestbo J, Houghton C, Singh D. Kolsum U, et al. Among authors: singh d. Respir Med. 2009 Jan;103(1):136-43. doi: 10.1016/j.rmed.2008.07.014. Epub 2008 Aug 28. Respir Med. 2009. PMID: 18760576 Free article.

6

MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.

Kirkham S, Kolsum U, Rousseau K, Singh D, Vestbo J, Thornton DJ. Kirkham S, et al. Among authors: singh d. Am J Respir Crit Care Med. 2008 Nov 15;178(10):1033-9. doi: 10.1164/rccm.200803-391OC. Epub 2008 Sep 5. Am J Respir Crit Care Med. 2008. PMID: 18776153 Free PMC article.

7

Prevalence of airflow obstruction in patients attending a rapid access chest pain clinic.

Francis HC, Colecliffe W, Hazell ML, Singh D, Niven R, Hagan GW, Spencer MD, Frank TL. Francis HC, et al. Among authors: singh d. Respir Med. 2009 May;103(5):736-42. doi: 10.1016/j.rmed.2008.11.016. Epub 2008 Dec 31. Respir Med. 2009. PMID: 19118993 Free article.

8

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators. Lomas DA, et al. Eur Respir J. 2009 Jul;34(1):95-102. doi: 10.1183/09031936.00156508. Epub 2009 Jan 22. Eur Respir J. 2009. PMID: 19164344 Free article.

9

COPD phenotype description using principal components analysis.

Roy K, Smith J, Kolsum U, Borrill Z, Vestbo J, Singh D. Roy K, et al. Among authors: singh d. Respir Res. 2009 May 29;10(1):41. doi: 10.1186/1465-9921-10-41. Respir Res. 2009. PMID: 19480658 Free PMC article.

10

A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients.

Singh D, Smyth L, Borrill Z, Sweeney L, Tal-Singer R. Singh D, et al. J Clin Pharmacol. 2010 Jan;50(1):94-100. doi: 10.1177/0091270009347873. Epub 2009 Oct 30. J Clin Pharmacol. 2010. PMID: 19880675 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,898 results

Search Page